次世代コンタクトレンズと人工視覚の世界市場-2023-2030

市場概要

次世代コンタクトレンズと人工視覚綴の世界市場は、2022年に1億7,250万米ドルに達し、2030年には最大6億800万米ドルに達することで有利な成長を示すと予測されます。世界の次世代コンタクトレンズと人工視覚器市場は、予測期間（2023-2030年）に17.7%のCAGRを示すと予想されています。

次世代コンタクトレンズは、従来のコンタクトレンズよりも進化しており、より幅広い視力問題を改善することができます。次世代コンタクトレンズと人工視覚器とは、眼球の天然レンズが除去されたり損傷した後に、その機能を代替する装置です。白内障や緑内障など、目の病気の治療にも使用されます。

老年人口における網膜疾患の有病率の上昇は、次世代コンタクトレンズと人工視覚市場の主要な促進要因の1つです。最も一般的な網膜疾患は、AMD、高血圧性網膜症、網膜上膜、BRVO、糖尿病性網膜症です。

市場力学

眼に関連する疾患の有病率の上昇

眼科疾患の頻度は世界的に増加しており、特にインドでは顕著です。例えば、世界保健機関（WHO）によると、世界で少なくとも22億人が近視や遠視に悩まされています。世界保健機関（WHO）によると、適切な診断と治療を受けていれば、少なくとも10億件の視力障害を回避できた可能性があるとされています。

多忙なライフスタイルのため、インドでは視力低下のケースが増加傾向にあります。14.5万人の患者のデータを含む大規模な調査によると、2019年にはドライアイ疾患の症例数が21,000件に増加しました。それによると、インドはドライアイ病の流行の危機に瀕しています。2030年には、都市部の人口の約40％が罹患すると言われています。

眼科医の不足

近年、眼科医のニーズは飛躍的に拡大しています。特に低開発国において顕著です。例えばインドでは人口9万人に1人の割合で眼科医がいるが、米国は1：15です。人口100万人あたりの平均眼科医数は経済発展状況によって異なり、低所得国の100万人あたり9人から高所得国の7900万人となっています。

COVID-19影響分析

パンデミックにより、次世代コンタクトレンズの研究開発の進展が妨げられています。ロックダウン、社会的距離の取り方、資金調達の制限により、研究所や研究施設に混乱が生じた。このため、新しいイノベーションを市場に投入するまでの期間が延びる可能性があります。

パンデミックは、世界のサプライチェーンに大きな影響を与え、多くの品目の製造や配送に支障をきたしています。これらの混乱は、材料、部品、製造装置の調達を含め、次世代コンタクトレンズの製造と入手に影響を与える可能性があります。

目次

第1章 調査手法とスコープ

• 調査手法
• 調査目的および調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 老年人口における網膜疾患の有病率の上昇
  • 抑制要因
    • 専門的な眼科医の不足
  • 機会
    • 製品の上市と認可の増加
  • 影響分析

第5章 産業分析

• ポーターの5フォース分析
• サプライチェーン分析
• 価格分析
• 法規制の分析

第6章 COVID-19の分析

第7章 製品タイプ別

• コンタクトレンズ
• 人工視覚

第8章 疾患別

• 緑内障
• 糖尿病
• 網膜色素変性症
• 網膜色素変性症
• その他

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第10章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A（合併・買収）分析

第11章 企業プロファイル

• Johnson & Johnson
• NIDEK
• Novartis
• Second Sight
• Menicon
• NJ Retina
• Interojo
• Pixium Vision
• OcuMedic
• Bausch & Lomb

第12章 付録

Market Overview

The Global Next Generation Contact Lenses And Visual Prostheses Market reached US$ 172.5 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 608.0 million by 2030. The global next generation contact lenses and visual prostheses market is expected to exhibit a CAGR of 17.7% during the forecast period (2023-2030).

Next-generation contact lenses are more advanced than traditional contact lenses and can correct a wider range of vision problems. next-generation contact lenses and visual prostheses are devices that replace the function of the eye's natural lens after it has been removed or damaged. They can be used to treat cataracts, glaucoma, and other eye conditions.

The rising prevalence of retinal diseases amongst the geriatric population is one of the major drivers for the next generation contact lenses & visual prostheses market. The most prevalent retinal diseases are AMD, hypertensive retinopathy, epiretinal membrane, BRVO, and diabetic retinopathy.

Market Dynamics

Rising Prevalence of Eye Related Diseases

The frequency of eye diseases is increasing globally, particularly in India. For instance, according to the World Health Organization (WHO), at least 2.2 billion people worldwide suffer from near- or far-sightedness. According to the World Health Organization, if the patient had received the proper diagnosis and care, at least one billion cases of vision impairment may have been avoided.

Due to a hectic lifestyle, cases of vision loss are on the rise in India. According to a large-scale study, which included data from 14.5 lakh patients, the number of cases of dry eye disease increased to 21,000 in 2019. It states that India is on the verge of a dry eye disease epidemic. By 2030, it will affect approximately 40% of the urban population.

Shortage of Ophthalmologists

Although the need for ophthalmologists has expanded dramatically in recent years. This is especially noticeable in underdeveloped nations. In India, for example, there is one ophthalmologist for every 90,000 people, but the US has a ratio of 1:15. The average number of ophthalmologists per million people varies according to economic development, ranging from 9 per million in low-income nations to 79 million in high-income countries.

COVID-19 Impact Analysis

The pandemic has hampered the advancement of next-generation contact lens research and development. Lockdowns, social distancing tactics, and restricted financing prospects have caused disruptions in laboratories and research facilities. This might possibly push back the timescale for bringing new innovations to market.

The pandemic has had a substantial impact on the global supply chain, causing interruptions in the manufacture and delivery of many items. These disruptions have the potential to influence the manufacture and availability of next-generation contact lenses, including the procurement of materials, components, and manufacturing equipment.

Segment Analysis

The global next generation contact lenses and visual prostheses market is segmented based on type of product , type of diseases and end user .

The Contact Lens Segment will be Dominated by Market Players During the Forecast Period

Contact lens is expected to be the dominating segment with the percentage around 81.3% in the forecast period as a result of product launches and approvals. For instance, Alcon Canada, for example, introduced new total toric lenses for astigmatic patients. Alcon, a worldwide pioneer in eye care devoted to helping people see brilliantly, announced the Canadian debut of a total of 30 for Astigmatism and Dailies Total 1 Astigmatism.

Alcon's line of reusable and daily disposable lenses has been expanded with high-performing solutions targeted at astigmatic patients. According to estimates, toric lenses (for astigmatic correction) are the fastest expanding section of the contact lens industry, providing an opportunity for eye care specialists to deliver excellent vision correction and patient care.

Geographical Analysis

North America is the Dominating Region During the Forecast Period

North America dominates the market for next-generation contact lenses and visual prostheses accounting for 42.1% and this trend is expected to continue during the projected period. The region's dominance is likely to continue during the projection period, owing to factors such as rising diabetes incidence, high disposable income, and growing awareness of modern technology for the treatment of eyesight impairment.

Due to factors such as improved healthcare infrastructure and the availability of innovative medicines for treating blindness, as well as economic expansion in countries such as India and China, the Asia Pacific area is expected to be the fastest-growing regional sector throughout the projection period.

Competitive Landscape

The major global players include: Johnson & Johnson, NIDEK, Novartis, Second Sight, NJ Retina, Interojo, OcuMedic, Bausch & Lomb, Pixium Vision, Menicon, and others.

• Why Purchase the Report?
• To visualize the global next generation contact lenses and visual prostheses market segmentation based on the type of product, type of diseases, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global next generation contact lenses and visual prostheses market level with all segments.
• Pdf report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global next generation contact lenses and visual prostheses market report would provide approximately 92 tables, 108 figures and 195 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by type of product
• 3.2. Snippet by type of diseases

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. The rising prevalence of retinal diseases amongst the geriatric population
  • 4.1.2. Restraints
    • 4.1.2.1. Shortage of Expert ophthalmologists
  • 4.1.3. Opportunity
    • 4.1.3.1. Increasing product launches and approvals
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's 5 Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID-19
  • 6.1.2. Scenario During COVID-19
  • 6.1.3. Scenario Post COVID-19
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturers' Strategic Initiatives
• 6.6. Conclusion

7. By Type of Product

• 7.1 Contact lens
• 7.2 Visual Prostheses

8. By Type of Diseases

• 8.1. Glaucoma
• 8.2. Diabetes
• 8.3. AMD
• 8.4. Retinitis Pigmentosa
• 8.5. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.5.1. The U.S.
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.5.1. Germany
    • 9.3.5.2. The UK
    • 9.3.5.3. France
    • 9.3.5.4. Italy
    • 9.3.5.5. Spain
    • 9.3.5.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.5.1. Brazil
    • 9.4.5.2. Argentina
    • 9.4.5.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.5.1. China
    • 9.5.5.2. India
    • 9.5.5.3. Japan
    • 9.5.5.4. Australia
    • 9.5.5.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Johnson & Johnson
• 11.2. NIDEK
• 11.3. Novartis
• 11.4. Second Sight
• 11.5. Menicon
• 11.6. NJ Retina
• 11.7. Interojo
• 11.8. Pixium Vision
• 11.9. OcuMedic
• 11.10. Bausch & Lomb

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us